LYVGEN BIOPHARMA HOLDINGS LTD has a total of 11 patent applications. Its first patent ever was published in 2016. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are XYPHOS BIOSCIENCES INC, SAGABIO CO LTD and LYVGEN BIOPHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Wang Jieyi | 11 |
#2 | Wang Yaolin | 4 |
#3 | Dong Liqun | 4 |
Publication | Filing date | Title |
---|---|---|
EP3601333A1 | Therapeutic agents and methods for enhancing immune responses in tumor microenvironment | |
US2018346569A1 | Anti-PD-1 antibodies and therapeutic uses thereof |